Literature DB >> 22674323

Decreased arthritis severity in cathepsin L-deficient mice is attributed to an impaired T helper cell compartment.

Uta Schurigt1, Rene Eilenstein, Mieczyslaw Gajda, Carola Leipner, Lisa Sevenich, Thomas Reinheckel, Christoph Peters, Bernd Wiederanders, Rolf Bräuer.   

Abstract

OBJECTIVE: Cathepsin L (CL) is potentially involved in joint destruction and in antigen presentation in rheumatoid arthritis. In order to define the roles of this protease in arthritis development we analysed the antigen-induced arthritis (AIA) in CL-deficient (CL(-/-)) mice.
METHODS: Antigen-induced arthritis was induced in CL(-/-) and wild-type mice. Complete CL deficiency resulted in an impaired positive selection of conventional CD4(+) T helper (Th) cells and finally in a reduced number of Th cells. Thus, we addressed the effect of this phenotype by rescuing CD4(+) Th cell numbers by transgenic expression of the human CL-like protease cathepsin V (hCV) in thymic epithelium of CL(-/-) mice [Tg(K14-hCV);CL(-/-)]. The arthritis development was monitored by measuring joint swelling. Joint inflammation and destruction were assessed histopathologically.
RESULTS: The severity of AIA was decreased in CL(-/-) mice characterized by reduced swelling, decreased inflammation and destruction, and diminished cellular and humoral immune responsiveness. AIA in Tg(K14-hCV);CL(-/-) mice was associated with a reconstitution of all parameters by normalization of the ratio of regulatory to conventional T cells.
CONCLUSIONS: Cathepsin L has a significant impact on AIA severity by influencing the selection of Th cell populations in the thymus, but seems not play any significant role in the direct joint destruction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22674323     DOI: 10.1007/s00011-012-0495-x

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  41 in total

Review 1.  T-cells in the pathogenesis of rheumatoid arthritis villains or accomplices?

Authors:  R W Kinne; E Palombo-Kinne; F Emmrich
Journal:  Biochim Biophys Acta       Date:  1997-04-12

2.  Cartilage proteoglycan aggregate is degraded more extensively by cathepsin L than by cathepsin B.

Authors:  Q Nguyen; J S Mort; P J Roughley
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

3.  Cathepsin L is essential for onset of autoimmune diabetes in NOD mice.

Authors:  René Maehr; Justine D Mintern; Ann E Herman; Ana-Maria Lennon-Duménil; Diane Mathis; Christophe Benoist; Hidde L Ploegh
Journal:  J Clin Invest       Date:  2005-09-22       Impact factor: 14.808

4.  Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.

Authors:  Wu-Shiun Hou; Weijie Li; Gernot Keyszer; Ekkehard Weber; Roger Levy; Michael J Klein; Ellen M Gravallese; Steven R Goldring; Dieter Brömme
Journal:  Arthritis Rheum       Date:  2002-03

5.  Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis: a parallel investigation by semiquantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry.

Authors:  G Keyszer; A Redlich; T Häupl; J Zacher; M Sparmann; U Engethüm; S Gay; G R Burmester
Journal:  Arthritis Rheum       Date:  1998-08

Review 6.  Synovial activation in rheumatoid arthritis.

Authors:  Caroline Ospelt; Michel Neidhart; Renate E Gay; Steffen Gay
Journal:  Front Biosci       Date:  2004-09-01

7.  Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen-induced arthritis: influence on T helper cell activation.

Authors:  D Pohlers; K Nissler; O Frey; J Simon; P K Petrow; R W Kinne; R Bräuer
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

8.  Cathepsin K deficiency partially inhibits, but does not prevent, bone destruction in human tumor necrosis factor-transgenic mice.

Authors:  Uta Schurigt; Klaus M Hummel; Peter K Petrow; Mieczyslaw Gajda; Renate Stöckigt; Peter Middel; Jochen Zwerina; Tobias Janik; Ricardo Bernhardt; Susann Schüler; Dieter Scharnweber; Felix Beckmann; Paul Saftig; George Kollias; Georg Schett; Bernd Wiederanders; Rolf Bräuer
Journal:  Arthritis Rheum       Date:  2008-02

9.  Regulation of collagenase activities of human cathepsins by glycosaminoglycans.

Authors:  Zhenqiang Li; Yoshiyuki Yasuda; Weijie Li; Matthew Bogyo; Norman Katz; Ronald E Gordon; Gregg B Fields; Dieter Brömme
Journal:  J Biol Chem       Date:  2003-11-26       Impact factor: 5.157

10.  Local expression of matrix metalloproteinases, cathepsins, and their inhibitors during the development of murine antigen-induced arthritis.

Authors:  Uta Schurigt; Nadine Stopfel; Marion Hückel; Christina Pfirschke; Bernd Wiederanders; Rolf Bräuer
Journal:  Arthritis Res Ther       Date:  2004-12-10       Impact factor: 5.156

View more
  3 in total

1.  Differential effects of specific cathepsin S inhibition in biocompartments from patients with primary Sjögren syndrome.

Authors:  Patrick Hargreaves; Douglas Daoudlarian; Michel Theron; Fabrice A Kolb; Marianne Manchester Young; Bernhard Reis; Andre Tiaden; Bettina Bannert; Diego Kyburz; Tobias Manigold
Journal:  Arthritis Res Ther       Date:  2019-07-18       Impact factor: 5.156

Review 2.  Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics.

Authors:  Caio P Gomes; Danilo E Fernandes; Fernanda Casimiro; Gustavo F da Mata; Michelle T Passos; Patricia Varela; Gianna Mastroianni-Kirsztajn; João Bosco Pesquero
Journal:  Front Cell Infect Microbiol       Date:  2020-12-08       Impact factor: 5.293

3.  Extreme genomic erosion after recurrent demographic bottlenecks in the highly endangered Iberian lynx.

Authors:  Federico Abascal; André Corvelo; Fernando Cruz; José L Villanueva-Cañas; Anna Vlasova; Marina Marcet-Houben; Begoña Martínez-Cruz; Jade Yu Cheng; Pablo Prieto; Víctor Quesada; Javier Quilez; Gang Li; Francisca García; Miriam Rubio-Camarillo; Leonor Frias; Paolo Ribeca; Salvador Capella-Gutiérrez; José M Rodríguez; Francisco Câmara; Ernesto Lowy; Luca Cozzuto; Ionas Erb; Michael L Tress; Jose L Rodriguez-Ales; Jorge Ruiz-Orera; Ferran Reverter; Mireia Casas-Marce; Laura Soriano; Javier R Arango; Sophia Derdak; Beatriz Galán; Julie Blanc; Marta Gut; Belen Lorente-Galdos; Marta Andrés-Nieto; Carlos López-Otín; Alfonso Valencia; Ivo Gut; José L García; Roderic Guigó; William J Murphy; Aurora Ruiz-Herrera; Tomas Marques-Bonet; Guglielmo Roma; Cedric Notredame; Thomas Mailund; M Mar Albà; Toni Gabaldón; Tyler Alioto; José A Godoy
Journal:  Genome Biol       Date:  2016-12-14       Impact factor: 13.583

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.